Back to 
NORDEA INVESTMENT MANAGEMENT AB
NORDEA INVESTMENT MANAGEMENT AB
CLDX
Showing 0 of 2 quarters
Position history for NORDEA INVESTMENT MANAGEMENT AB's holdings in CELLDEX THERAPEUTICS INC NEW
No. Nordea Investment Management exited its CLDX (Celldex Therapeutics) position in Q2 2019. Its Q1 2019 13F listed 666 shares worth $3,000. Nordea Investment Management already held CLDX in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.